Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  New England Journal of Medicine

• Publication date

  1993-12-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199312093292417PMID 8232502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statistical Methods for Survival Data Analysis

  1994cited by this paper
• Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.

  1992cited by this paper
• Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure.

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

  1991cited by this paper
• Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group.

  1991cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled, crossover trial.

  1991cited by this paper
• Digoxin, Converting-Enzyme Inhibition (Quinapril), and the Combination in Patients with Congestive Heart Failure Functional Class II and Sinus Rhythm

  1990cited by this paper
• Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy.

  1990cited by this paper
• Comparison of enalapril versus digoxin for congestive heart failure.

  1989cited by this paper
• Statistical Methodology in the Pharmaceutical Sciences

  1989cited by this paper
• Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure.

  1989cited by this paper
• A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.

  1989cited by this paper
• Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.

  1989cited by this paper
• Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

  1989cited by this paper
• A controlled trial of digoxin in congestive heart failure.

  1988cited by this paper
• Captopril Versus Digoxin in Mild‐Moderate Chronic Heart Failure: A Crossover Study

  1987cited by this paper
• Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire

  1987cited by this paper
• Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study.

  1985cited by this paper
• Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure.

  1985cited by this paper
• The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

  1985cited by this paper
• Effect of digitalis treatment on survival after acute myocardial infarction.

  1985cited by this paper
• A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.

  1985cited by this paper
• Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure.

  1983cited by this paper
• Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm.

  1983cited by this paper
• Digoxin Withdrawal After Cardiac Failure in Patients with Sinus Rhythm

  1983cited by this paper
• Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm.

  1982cited by this paper
• Heart failure in outpatients: a randomized trial of digoxin versus placebo.

  1982cited by this paper
• Possible mechanism of the inhibitory effect of ouabain on renin secretion from rat renal cortical slices.

  1979cited by this paper
• Discontinuation of maintenance digoxin therapy in general practice.

  1977cited by this paper
• Methods of exercise testing. Step test, bicycle, treadmill, isometrics.

  1974cited by this paper
• Maintenance Digoxin in Elderly Patients

  1970cited by this paper

• Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions—Part II: Combination Therapy

  2024cites this paper
• Serum Cystatin C as a Risk Factor for Supratherapeutic Digoxin Concentration in Elderly Patients with Heart Failure and Chronic Kidney Disease

  2024cites this paper
• The First Dedicated Comprehensive Heart Failure Program in the US: the Division of Circulatory Physiology at Columbia Presbyterian (1992-2004).

  2023cites this paper
• The effects of Digoxin use on long-term prognosis in patients with heart failure with reduced ejection fraction.

  2023cites this paper
• Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency

  2022cites this paper
• Analysis of Intoxication, Rehospitalization, and One-year Survival of Heart Failure Patients Receiving Digoxin at Harapan Kita National Cardiovascular Center, Jakarta, Indonesia: A Cross Section-observational Study

  2022cites this paper
• Impact of Digoxin Use on Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction

  2022cites this paper
• Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure

  2022cites this paper
• The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?

  2022cites this paper
• Digoxin Use in Atrial Fibrillation; Insights from National Ambulatory Medical Care Survey.

  2022cites this paper
• Management of Cardiovascular Diseases in the Elderly

  2022cites this paper
• Diseases of the Cardiovascular System

  2021cites this paper
• Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study

  2021cites this paper
• Eisen und Digitalis bei Herzinsuffizienz

  2021cites this paper
• Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials

  2021cites this paper
• Clinical Profiles and Outcomes of Heart Failure in Five African Countries: Results from INTER-CHF Study

  2021cites this paper
• Closing the Digitalis Divide: Back to the Basics of Randomized Controlled Trials

  2021cites this paper
• Heart Failure: Past, Present, Future.

  2021cites this paper
• Congestive heart failure

  2020cites this paper
• Heart Failure as a Consequence of Ischemic Heart Disease

  2020cites this paper
• Increase in PKCα Activity during Heart Failure Despite the Stimulation of PKCα Braking Mechanism

  2020cites this paper
• Contemporary Medical Therapy for Heart Failure Patients with Reduced Ejection Fraction

  2020cites this paper
• Heart Failure due to Left Ventricular Systolic Dysfunction

  2020cites this paper
• Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction

  2020cites this paper
• Heart Failure – Pathophysiology and Current Therapeutic Implications

  2020cites this paper
• Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.

  2020cites this paper
• Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.

  2020cites this paper
• Challenges and Future in Precision Cardiovascular Medicine

  2019cites this paper
• Does digoxin cause more harm than good?

  2019cites this paper
• An up-to-date review of digoxin toxicity and its management

  2019cites this paper
• Digitoxin Attenuates Heart Failure, Reduces Myocardial Hypertrophy, and Preserves the Calcium-Binding Proteins in Infarcted Rats

  2019cites this paper
• Effect of digitalis level on readmission and mortality rate among heart failure reduced ejection fraction patients

  2019cites this paper
• Pharmacotherapy in Heart Failure (I): Renin-Angiotensin-Aldosterone System (incl. ARNI), Diuretics, Digoxin and Statins

  2019cites this paper
• Digoxin and prognosis of heart failure in older patients with preserved ejection fraction: Importance of heart rate. Results from an observational and multicenter study.

  2019cites this paper
• Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

  2019cites this paper
• Interrupção da digoxina e desfechos em pacientes com insuficiência cardíaca com fração de ejeção reduzida

  2019cites this paper
• Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach

  2019cites this paper
• Influence of OATP1B1 and OATP1B3 mutations and glomerular filtration rate on trough serum digoxin concentration in the Chinese population

  2019cites this paper
• Heart Failure: A review of disease, therapies and medications with a focus on symptoms, function, and quality of life.

  2019cites this paper
• Quelles sont les difficultés rencontrées par les médecins généralistes ornais concernant la prise en charge thérapeutique de l’insuffisance cardiaque chronique systolique ?

  2019cites this paper
• Is the Digitalis Leaf Still Withering?

  2019cites this paper
• Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

  2019cites this paper
• Estrategia de desprescripción en pacientes pluripatológicos.

  2019influential citation
• Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF‐ACTION) randomized controlled trial

  2018cites this paper
• Acute Decompensated Heart Failure

  2018influential citation
• Evidence-Based Management of the Patient with Congestive Heart Failure

  2018cites this paper
• Cardiovascular Genetics and Genomics

  2018cites this paper
• Polypharmacy, the Good Prescribing Continuum, and the Ethics of Deprescribing

  2018cites this paper
• Management of advanced heart failure: a review

  2018cites this paper
• Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia

  2018cites this paper
• Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community

  2018cites this paper
• Inherited Cardiac Muscle Disorders: Hypertrophic and Restrictive Cardiomyopathies

  2018cites this paper
• Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care

  2017cites this paper
• Is an Admission for Decompensated Heart Failure Inevitable?

  2017influential citation
• The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study.

  2017cites this paper
• Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years.

  2017cites this paper
• Late In-Hospital Management of Patients Hospitalized with Acute Heart Failure.

  2017cites this paper
• Ground Hog Day: Do We Need Another Analysis of Diuretic Dose and Outcomes in Heart Failure Patients?

  2017cites this paper
• Optimisation of pacemaker therapy for cardiac function

  2017cites this paper
• The Role of Positive Inotropic Drugs in the Treatment of Older Adults with Heart Failure and Reduced Ejection Fraction.

  2017cites this paper
• An Evaluation in Current Clinical Practice

  2017cites this paper
• Left ventricular ejection fraction as therapeutic target: is it the ideal marker?

  2017cites this paper
• Digoxin and Heart Failure: Are We Clear Yet?

  2017cites this paper
• Long-Term Use of Cardiovascular Medications: Identifying and Encouraging Optimal Duration

  2017cites this paper
• Systematic review of economic burden of heart failure

  2017cites this paper
• Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice.

  2017cites this paper
• Prescription pattern in patients having heart failure in a south Indian tertiary care hospital: A retrospective study

  2017cites this paper
• Outpatient Medication Titration in Acute Heart Failure

  2017cites this paper
• Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model.

  2017cites this paper
• Rational and design of a randomized, double‐blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC‐1 trial

  2017cites this paper
• Korean Guidelines for Diagnosis and Management of Chronic Heart Failure

  2017cites this paper
• Trifecta St. Jude medical® aortic valve in pulmonary position

  2017cites this paper
• Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation.

  2016cites this paper
• Development of Therapeutics for Heart Failure : Expedited Commentary

  2016cites this paper
• Exercise Intolerance in Heart Failure: Did We Forget the Brain?

  2016cites this paper
• The Established Therapies: HF-PEF and HF-REF

  2016cites this paper
• Impacto pronóstico de la fibrilación auricular en la insuficiencia cardíaca desde su diagnóstico inicial

  2016cites this paper
• Precision medicine in cardiology

  2016cites this paper
• 2 Packer Unbelievable Folly of Clinical Trials drug that prolongs life in heart failure

  2016cites this paper
• The Future of Heart Failure Diagnosis, Therapy, and Management.

  2016cites this paper
• Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.

  2016cites this paper
• Digoxin: The good and the bad.

  2016cites this paper
• Targeting digoxin dosing to serum concentration: is the bullseye too small?

  2016cites this paper
• Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?

  2016cites this paper
• Digoxin toxicity: Case for retiring its use in elderly patients?

  2016cites this paper
• Falla cardíaca crónica etapa C

  2016cites this paper
• Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies.

  2016cites this paper
• Unbelievable Folly of Clinical Trials in Heart Failure: The Inconvenient Truth About How Investigators and Guidelines Weigh Evidence.

  2016cites this paper
• Study of Clinical Profile in Hypertensive Patients

  2016cites this paper
• Chronic Heart Failure Clinical Practice Guidelines’ Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

  2016cites this paper
• Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective

  2016cites this paper
• The Room Where It Happens: A Skeptic's Analysis of the New Heart Failure Guidelines.

  2016cites this paper
• Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial.

  2016cites this paper
• Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells

  2016cites this paper
• Contemporary Controversies in Digoxin Use in Systolic Heart Failure

  2016cites this paper
• CARDIAC GLYCOSIDES USES IN HEART

  2016cites this paper
• Management of Patients With Recovered Systolic Function.

  2016cites this paper
• Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.

  2016cites this paper
• Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation.

  2015cites this paper
• Use of digoxin in chronic systolic heart failure in current era.

  2015cites this paper